NCT01557166 - Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea | Biotech Hunter

Enrollment

359

Participants

Timeline

Start Date

June 7, 2012

Primary Completion Date

June 1, 2013

Study Completion Date

June 17, 2013

Conditions

Metabolism and Nutrition DisorderObesityObstructive Sleep Apnoea

Interventions

DRUG

liraglutide

3.0 mg liraglutide administered subcutaneously (s.c., under the skin) once daily for 32 weeks + diet and exercise

DRUG

placebo

Placebo administered subcutaneously (s.c., under the skin) once daily for 32 weeks + diet and exercise

Trial Locations (42)

10019

Novo Nordisk Investigational Site, New York

10065

Novo Nordisk Investigational Site, New York

19118

Novo Nordisk Investigational Site, Philadelphia

19140

Novo Nordisk Investigational Site, Philadelphia

22182

Novo Nordisk Investigational Site, Vienna

28401

Novo Nordisk Investigational Site, Wilmington

30342

Novo Nordisk Investigational Site, Atlanta

31201

Novo Nordisk Investigational Site, Macon

33024

Novo Nordisk Investigational Site, Hollywood

33143

Novo Nordisk Investigational Site, South Miami

33155

Novo Nordisk Investigational Site, Miami

33409

Novo Nordisk Investigational Site, West Palm Beach

33511

Novo Nordisk Investigational Site, Brandon

33603

Novo Nordisk Investigational Site, Tampa

33707

Novo Nordisk Investigational Site, St. Petersburg

40218

Novo Nordisk Investigational Site, Louisville

60061

Novo Nordisk Investigational Site, Vernon Hills

60634

Novo Nordisk Investigational Site, Chicago

63017

Novo Nordisk Investigational Site, Chesterfield

66212

Novo Nordisk Investigational Site, Overland Park

75231

Novo Nordisk Investigational Site, Dallas

75234

Novo Nordisk Investigational Site, Dallas

76135

Novo Nordisk Investigational Site, Fort Worth

90404

Novo Nordisk Investigational Site, Santa Monica

91206

Novo Nordisk Investigational Site, Glendale

92054

Novo Nordisk Investigational Site, Oceanside

92868

Novo Nordisk Investigational Site, Orange

94063

Novo Nordisk Investigational Site, Redwood City

92103-5801

Novo Nordisk Investigational Site, San Diego

41017-3464

Novo Nordisk Investigational Site, Crestview Hills

20815-6905

Novo Nordisk Investigational Site, Chevy Chase

02747

Novo Nordisk Investigational Site, North Dartmouth

49024-4889

Novo Nordisk Investigational Site, Portage

43017-3521

Novo Nordisk Investigational Site, Dublin

19104-3317

Novo Nordisk Investigational Site, Philadelphia

02886

Novo Nordisk Investigational Site, Warwick

29201-2951

Novo Nordisk Investigational Site, Columbia

L7R 1E2

Novo Nordisk Investigational Site, Burlington

L8L 5G8

Novo Nordisk Investigational Site, Hamilton

M4P 1P2

Novo Nordisk Investigational Site, Toronto

M5M 1C7

Novo Nordisk Investigational Site, Toronto

M5M1C7

Novo Nordisk Investigational Site, Toronto